Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study
Crossref DOI link: https://doi.org/10.1007/s10147-015-0834-3
Published Online: 2015-05-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Osawa, Masahiro
Kudoh, Shoji
Sakai, Fumikazu
Endo, Masahiro
Hamaguchi, Tetsuya
Ogino, Yumiko
Yoneoka, Miyo
Sakaguchi, Motonobu
Nishimoto, Hiroyuki
Gemma, Akihiko
License valid from 2015-05-13